Información del producto
VU591 is a drug that has been developed to treat chronic kidney disease. It is a vasopressin type 1 receptor (V1R) agonist, which increases the synthesis of nitric oxide and prostaglandins in the vascular system, thereby lowering blood pressure and improving renal function. VU591 has been shown to be effective in animal models of cardiovascular diseases and it has been used in clinical trials for human subjects with type 1 diabetes mellitus or hypertension. VU591 acts as a natriuretic agent by binding to the G-protein coupled receptors on the surface of cells in various tissues and increasing intracellular cAMP levels. The drug also interacts with other drugs, such as amlodipine, thereby inhibiting its effects on blood pressure.
Propiedades químicas
Consulta técnica sobre: 3D-XYB81074 VU591
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
